Literature DB >> 2142672

Prevalence of the 1.8 kb complement factor H mRNA in human lung.

M J Demares1, C Davrinche.   

Abstract

Human complement factor H, described as a 155,000 molecular weight (MW) component, is a key factor in the control of the alternative pathway of complement activation. Using two human factor H cDNA clones, designated R2a (a clone derived from the 3' end of the factor H coding sequence) and B38-1 (a clone derived from the 5' end of the factor H coding sequence), as probes, three factor H-specific transcripts of 4.3 kb, 1.8 kb and 1.5 kb are usually detected in human liver, in equal abundance. Using these two factor H cDNAs to probe human lung RNA, there was evidence of a singular distribution of the factor H mRNA species in human lung compared to liver, in equal prevalence of the 1.8 kb factor H mRNA over the 4.3 kb factor H mRNA (a three- to fourfold difference). No significant expression of the 1.5 kb mRNA was detected. The prevalence of the 1.8 kb complement factor H mRNA leads to the speculation that the predominant factor H form biosynthesized in lung tissue is a truncated form of the factor H molecule.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2142672      PMCID: PMC1384185     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  28 in total

1.  In vitro activation of a human macrophage-like cell line.

Authors:  H S Koren; S J Anderson; J W Larrick
Journal:  Nature       Date:  1979-05-24       Impact factor: 49.962

2.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

3.  Effect of trypsinization on the activity of human factor H.

Authors:  K Hong; T Kinoshita; Y Dohi; K Inoue
Journal:  J Immunol       Date:  1982-08       Impact factor: 5.422

4.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

5.  Characterization of a human macrophage-like cell line stimulated in vitro: a model of macrophage functions.

Authors:  J W Larrick; D G Fischer; S J Anderson; H S Koren
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

6.  Establishment and characterization of a human histiocytic lymphoma cell line (U-937).

Authors:  C Sundström; K Nilsson
Journal:  Int J Cancer       Date:  1976-05-15       Impact factor: 7.396

7.  Lysine residues, but not carbohydrates, are required for the regulatory function of H on the amplification C3 convertase of complement.

Authors:  M H Jouvin; M D Kazatchkine; A Cahour; N Bernard
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

8.  Truncated forms of human complement factor H.

Authors:  M Fontaine; M J Demares; V Koistinen; A J Day; C Davrinche; R B Sim; J Ripoche
Journal:  Biochem J       Date:  1989-03-15       Impact factor: 3.857

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

10.  Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes.

Authors:  K Whaley
Journal:  J Exp Med       Date:  1980-03-01       Impact factor: 14.307

View more
  1 in total

1.  Enhanced bacteremia in human factor H transgenic rats infected by Neisseria meningitidis.

Authors:  David M Vu; Jutamas Shaughnessy; Lisa A Lewis; Sanjay Ram; Peter A Rice; Dan M Granoff
Journal:  Infect Immun       Date:  2011-11-21       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.